Skip to content
ciprofibrate

Structure via PubChem · Public domain (PubChem)

EntityQ3496452· pop 12· linked from 137 articles

ciprofibrate

Sign in to save

Also known as WIN-35833

Ciprofibrate is a fibrate that was developed as a lipid-lowering agent.

Chemical data

Formula
C13H14Cl2O3
Molecular weight
289.15 g/mol
IUPAC name
2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid
SMILES
CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
InChIKey
KPSRODZRAIWAKH-UHFFFAOYSA-N
XLogP
3.4
Polar surface area
46.5 Ų
H-bond donors
1
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1985
Admin. routes
oral
Indications
cardiovascular disease

via ChEMBL · EBI

Wikidata facts

Mass
288.032
Has use
medication
Show 4 more facts
chemical formula
C₁₃H₁₄Cl₂O₃
canonical SMILES
CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
World Health Organisation international non-proprietary name
ciprofibrate
significant drug interaction
pravastatin
Sources (4)

via Wikidata · CC0

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

Ciprofibrate is a fibrate that was developed as a lipid-lowering agent.

It was patented in 1972 and approved for medical use in 1985.

Excerpted from Wikipedia’s “ciprofibrate” article, available under the CC BY-SA 4.0 licence.